Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosis.
作者信息
Kristen Arnt V, Biener Moritz, Hegenbart Ute, Hardt Stefan, Schnabel Philipp A, Röcken Christoph, Schonland Stefan O, Katus Hugo A, Giannitsis Evangelos
机构信息
Department of Cardiology, Angiology, and Respiratory Medicine, Heidelberg University, Im Neuenheimer Feld 410, D-69120 Heidelberg, Germany.
Department of Haematology and Oncology, Heidelberg University, Im Neuenheimer Feld 410, D-69120 Heidelberg, Germany.
出版信息
Int J Cardiol. 2014 Oct 20;176(3):1113-5. doi: 10.1016/j.ijcard.2014.07.106. Epub 2014 Aug 1.
PMID:25115253
Abstract
摘要
Zotero 插件